Register for Dr. Ronald Gerridzen Webinar: The Artificial Sphincter in the Management of Urinary Incontinence Following Prostate Cancer Therapy
On Tuesday, September 29 at 7pm EDT, join Dr. Ronald Gerridzen as he presents "The Artificial Sphincter in the Management of Urinary Incontinence Following Prostate Cancer Therapy."
During this webinar, you'll learn about
How prostate cancer is common and often necessitates treatment which might result in detrimental effects on urinary control and sexual function.
The AMS 800 artificial urinary sphincter is an ingenious device developed and refined starting in 1973.
It is very effective in restoring reasonably good urinary control and thus quality of life for men whose urinary control has been moderately to severely affected by their prostate cancer treatment(s).
This presentation will focus on the history of the AMS 800, its current format, indications for its use, pros and cons, and results.us2.campaign-archive2.com/?u=381dca877e43c44046caa6dd1&id=ff2830f572&e=9d55015d7b
DX in May 2011, Age 52, Stage T2c, GG 8-10, PSA=10.6
EBR + Brachy Seed Implants + HT(22.5 mg Lupron for 1 year)
Nov 2011,PSA 0,
Feb 2012, PSA 0 (T=1.66), Nov 2012, 0.29 T=4.0
May 2013 0.32 T=5.11, Nov 2013 - 0.20 T = normal
May 2014 0.22, Nov 2014 - 0.60,
May 2015, PSA=0.7